A. Fowler

Characterization of interferon-γ-treated melanoma tumor cells for use in dendritic cell-based immunotherapy.

R. Dillman, A. Cornforth, A. Fowler, 2011, Cancer biotherapy & radiopharmaceuticals.

Establishment of stable cell lines for personalized melanoma cell vaccine

S. Selvan, R. Dillman, M. Ravindranath, 2010, Melanoma research.

Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival

R. Dillman, A. Cornforth, A. Fowler, 2010, Cancer Immunology, Immunotherapy.

Monitoring response to treatment in melanoma patients: Potential of a serum glycomic marker

S. Selvan, R. Dillman, M. Ravindranath, 2008, International journal of cancer.

Increases in Serum TARC/CCL17 Levels Are Associated with Progression-Free Survival in Advanced Melanoma Patients in Response to Dendritic Cell-Based Immunotherapy

R. Dillman, A. Cornforth, A. Fowler, 2009, Journal of Clinical Immunology.